Overview

Study to Investigate the Effects Single Oral Dose of AZD1386 (Capsaicin)

Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
A double-blind, randomized, single-centre, placebo-controlled, crossover study to investigate the effects of a single oral dose of AZD1386 on intradermal capsaicin evoked pain symptoms and heat sensitivity in healthy volunteers
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca
Treatments:
Capsaicin